GSK3B and Alzheimer disease: We also highlight the role of the GSK3β (glycogen synthase kinase 3β)- and DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A)-dependent pathological mechanisms that contribute to the development of both T2D and AD.